MARKET

MRK

MRK

Merck & Co
NYSE
129.45
+0.19
+0.15%
After Hours: 130.00 +0.55 +0.42% 19:52 02/23 EST
OPEN
129.79
PREV CLOSE
129.26
HIGH
130.24
LOW
128.86
VOLUME
5.18M
TURNOVER
0
52 WEEK HIGH
130.24
52 WEEK LOW
98.43
MARKET CAP
328.03B
P/E (TTM)
903.35
1D
5D
1M
3M
1Y
5Y
Pfizer: Finally, A Dividend Stock Worth Buying
Seeking Alpha · 1d ago
Pharma Stock Roundup: Pfizer's Velsipity Receives EU Nod, ABBV Gets New CEO & More
NASDAQ · 2d ago
Merck Says Keytruda Combination Gets Positive EU CHMP Opinion As Neoadjuvant Treatment For NSCLC
NASDAQ · 2d ago
Bristol Myers blood disorder therapy endorsed in EU for label expansion
Bristol Myers blood disorder therapy endorsed in EU for label expansion. European Medicines Agency has endorsed its blood disorder Therapy Reblozyl to expand its label in the region. Bristol Myers has a partnership with Merck to jointly advance and promote the drug in the EU.
Seeking Alpha · 2d ago
Merck wins EU backing for Keytruda use in resectable lung cancer
Merck wins EU backing for Keytruda use in resectable lung cancer. European Medicines Agency endorsed its blockbuster anti-PD-1 therapy in combination with chemotherapy. The drug will be used to treat a form of lung cancer called non-small cell lung cancer (NSCLC)
Seeking Alpha · 2d ago
Moderna (MRNA) Beats on Q4 Earnings & Sales, Reiterates View
NASDAQ · 3d ago
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
Pfizer completed its acquisition of Seagen Inc, a biotechnology leader in transformative cancer medicines. Moderna Inc is also betting its growth story on revolutionizing cancer treatment. Mainz Biomed N.V. Is making breakthroughs in early diagnostics. Early screening and better prevention are key to changing the odds in the battle against cancer.
Benzinga · 3d ago
USMV, ZSL: Big ETF Outflows
NASDAQ · 3d ago
More
About MRK
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, including biological therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription for the treatment of human disorders. It sells human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers. The Company’s Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products as well as health management solutions for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s product MK-7240 is used for the treatment of immune-mediated diseases including ulcerative colitis, and Crohn’s disease.

Webull offers Merck & Co Inc stock information, including NYSE: MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.